Structure Therapeutics (GPCR) IPO deck Members Public

Structure Therapeutics is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases

Debarshi Ghosh
IPO

Vox Royalty $VOXR Members Public

Vox Royalty is an unusual and successful marriage of data mining and precious metals royalty investing. It is delivering strong growth and expanding profitability. It's a precious metals stock that even a technology geek can love.

Kris Tuttle
MicroCap

TXO Energy Partners (TXO) IPO deck Members Public

TXO Energy Partners, L.P. is a master limited partnership focused on the acquisition, development, optimization and exploitation of conventional oil, natural gas, and natural gas liquid reserves in North America.

Debarshi Ghosh
IPO

IPO Candy Year in Review 2022 Members Public

A review of all the regular-way IPO transactions of 2022 to find potential new longs and shorts for 2023. Members can download the PDF and the Excel sheet.

Kris Tuttle
Sectors

Lucy Scientific Discovery (LSDI) IPO deck Members Public

Lucy Scientific Discovery is an early-stage psychotropics contract manufacturing company focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry.

Debarshi Ghosh
Healthcare

Elate Group (ELGP) IPO deck Members Public

Elate Group is a moving and storage company providing domestic concierge services and international relocation solutions for residential, commercial and government clients in the United States and Canada.

Debarshi Ghosh
IPO

Skyward (SKWD) IPO deck Members Public

Skyward Specialty is a rapidly growing specialty insurance company, delivering commercial property and casualty products and solutions on a non-admitted and admitted basis.

Debarshi Ghosh
IPO

Coya Therapeutics (COYA) IPO deck Members Public

Coya Therapeutics is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (“Tregs”).

Debarshi Ghosh
IPO